West Pharma and Amgen

The following from West Pharma's third quarter 2015 results would suggest they are not totally out of the picture with Amgen for the over 1ml wearable injectors:

"The development of our SmartDose electronic wearable injector continues to gain momentum in the marketplace, with multiple active development programs in place, including a recently submitted application to the U.S. Food and Drug Administration (FDA) for Amgen's Repatha™ (evolocumab). The application is for a 420 mg monthly dose to be administered as a single injection utilizing the SmartDose injector, which features a silicone-free Daikyo Crystal Zenith cartridge and a FluroTec^® coated piston containment system." (my underlining)